
FDA implements updated iPLEDGE REMS requirements for isotretinoin, allowing at-home pregnancy testing and reducing prescription and counseling burdens.
Are some doctors overlooking symptoms of new-onset atopic dermatitis (AD) among older patients? How do diagnostic workups for new-onset AD differ for with teens, adults, or the elderly compared to young children? Do recently developed systemic biologic therapies show promise? In this educational supplement, three physician experts discuss approaches to treating the chronic, relapsing disease.






